Putting evidence into context: Some advice for guideline writers

Evidence-Based Nursing

Volumn 11, Issue 1, 2008, Pages 6-8

  Dartnell, Jonathan ^a   Hemming, Mary ^a   Collier, Joe ^b   Ollenschlaeger, Guenter ^c,d  

^a Therapeutic Guidelines Limited   (Australia)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c Agency for Quality in Medicine   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EVIDENCE BASED MEDICINE; PRACTICE GUIDELINE; STANDARD;

EVIDENCE-BASED MEDICINE; PRACTICE GUIDELINES AS TOPIC;

EID: 38749133032     PISSN: 13676539     EISSN: 14689618     Source Type: Journal    
DOI: 10.1136/ebn.11.1.6     Document Type: Note

References (23)

1. Sackett DL, Straus SE, Richardson WS, et al. Evidence-based medicine: how to practice and teach EBM. 2nd ed. Edinburgh: Churchill Livingstone; 2000.
2. Haynes RB. What kind of evidence is it that Evidence-Based Medicine advocates want health care providers and consumers to pay attention to? BMC Health Serv Res 2002;2:3.
3. Burgers JS, Grol R, Klazinga NS, et al. Towards evidence-based clinical practice: an international survey of 18 clinical guideline programs. Int J Qual Health Care 2003;15:31-45.
4. Ollenschlager G, Marshall C, Qureshi S, et al. Improving the quality of health care: using international collaboration to inform guideline programmes by founding the Guidelines International Network (G-I-N). Qual Saf Health Care 2004;13:455-60.
5. Houtepen R, Biller-Andorno N, Dickenson D, et al. Recommendations from the Evibase Project. In: ter Meulen R, Biller-Andorno N, Lenk C, et al, editors. Ethical issues of evidence-based practice in medicine and health care. Heidelberg/New York: Springer, 2005:173-6.
6. Scott IA, Greenberg PB. Cautionary tales in the clinical interpretation of therapeutic trial reports. Intern Med J 2005;35:611-21.
7. Melander H, Ahlqvist-Rastad J, Meijer G, et al. Evidence b(i)ased medicine- selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 2003;326:1171-3.
8. Scott I, Greenberg P, Poole P, et al. Cautionary tales in the interpretation of systematic reviews of therapy trials. Intern Med J 2006;36:587-99.
9. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ 2001;323:101-5.
10. Cohen AM, Stavri PZ, Hersh WR. A categorization and analysis of the criticisms of Evidence-Based Medicine. Int J Med Inform 2004;73:35-43.
11. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. BMJ 1997;315:640-5.
12. Montori VM, Devereaux PJ, Adhikari NK, et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005;294:2203-9.
13. Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.
14. Glasziou P, Vandenbroucke JP, Chalmers I. Assessing the quality of research. BMJ 2004;328:39-41.
15. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490.
16. Burgers JS, van Everdingen JJ. Beyond the evidence in clinical guidelines. Lancet 2004;364:392-3.
17. Maxwell SR. Evidence based prescribing. BMJ 2005;331:247-8.
18. International Society of Drug Bulletins. Starting or strengthening a drug bulletin. A practical manual. International Society of Drug Bulletins and World Health Organization, 2005. www.who.int/entity/medicines/areas/rational_use/ startingstrengdrugbulletin.pdf (accessed 17 Dec 2007).
19. Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn't. BMJ 1996;312:71-2.
20. The AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care 2003;12:18-23.
21. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004;8:iii-iv, 1-72.
22. Michie S, Johnston M. Changing clinical behaviour by making guidelines specific. BMJ 2004;328:343-5.
23. eTG complete. Melbourne: Therapeutic Guidelines Limited, 2007. www.tg.com.au (accessed 17 Dec 2007).